The Current Development of Flavivirus Vaccines, Diseases Control and Epidemiological Situation

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: 31 March 2025 | Viewed by 34

Special Issue Editor


E-Mail
Guest Editor
Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan
Interests: Japanese encephalitis vaccine; arbovirus infection; virus evolution; seroepidemiological survey; host-virus cophylogeny; zoonotic diseases

Special Issue Information

Dear Colleagues,

The Flavivirus genus consists of viruses that can cause serious diseases, such as Dengue, Zika, West Nile, yellow fever, Japanese encephalitis, and tick-borne encephalitis. This Special Issue focuses on sharing the latest developments and vaccine trends in Flavivirus infection. We welcome your original research articles, reviews, and perspectives on novel experimental vaccine candidates, vaccine strategies, immune responses, and concerns or optimizations related to vaccine strategies. We also welcome related topics on the epidemiological situation and trends of Flavivirus infection.

Dr. Satoru Arai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • novel vaccine candidates
  • vaccine development
  • vaccination
  • emerging infectious diseases
  • vaccine efficacy
  • vaccination strategies
  • immunization strategies and public health

Published Papers

This special issue is now open for submission.
Back to TopTop